ramelteon has been researched along with Adenoma, Prostatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiguro, H; Ito, H; Kawahara, T; Kubota, Y; Matsuzaki, J; Miyamoto, H; Morita, S; Sakata, R; Tanaka, K; Terao, H; Uemura, H | 1 |
1 trial(s) available for ramelteon and Adenoma, Prostatic
| Article | Year |
|---|---|
Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Antioxidants; Drug Therapy, Combination; Humans; Indenes; Male; Nocturia; Pilot Projects; Prostatic Hyperplasia; Treatment Outcome | 2013 |